Sweden's recent decision to terminate a contract with a scientific publisher, because the publisher was not making sufficient progress towards Sweden's demands for open access, has given rise to much jubilation in some quarters. It is argued that Sweden has stood up for the interests of the broad general public against the pecuniary interests of the scientific publishing industry.
Despite successful bans on the veterinary drug diclofenac in Nepal and parts of India, a decade-long undercover investigation reveals that toxic alternatives like flunixin and nimesulide are rapidly replacing it, posing a renewed existential threat to the region’s critically endangered vulture populations.